Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ELVR | Collard Sylvain | President Canada & Group COO | 02.11.2026 | Verkauf | 2,15 | 32.651 | 70.174 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 447,19 | 273 | 122.083 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 446,05 | 827 | 368.883 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 444,85 | 160 | 71.176 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 443,81 | 440 | 195.276 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 442,61 | 480 | 212.453 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 441,34 | 2.343 | 1.034.060 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 440,44 | 1.720 | 757.557 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 439,25 | 1.160 | 509.530 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 438,22 | 240 | 105.173 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 437,07 | 560 | 244.759 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 436,20 | 1.660 | 724.092 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 435,25 | 321 | 139.715 | Form 4 |
| ELV | Kaye Mark | EVP & CFO | 22.10.2026 | Verkauf | 434,00 | 400 | 173.600 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 19.10.2026 | Verkauf | 38,48 | 6.018 | 231.546 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 19.10.2026 | Verkauf | 38,47 | 5.000 | 192.342 | Form 4 |
| ELF | Franks Joshua Allen | SVP, Operations | 15.10.2026 | Verkauf | 110,15 | 7.926 | 873.072 | Form 4 |
| ELAN | Bettington Timothy J | SEE REMARKS | 15.10.2026 | Verkauf | 23,00 | 4.350 | 100.050 | Form 4 |
| ELF | Franks Joshua Allen | SVP, Operations | 12.10.2026 | Verkauf | 110,01 | 8.366 | 920.310 | Form 4 |
| ELF | Amin Tarang | Chief Executive Officer | 01.10.2026 | Verkauf | 105,01 | 2.026 | 212.746 | Form 4 |
| ELF | Amin Tarang | Chief Executive Officer | 01.10.2026 | Verkauf | 103,66 | 21.902 | 2.270.304 | Form 4 |
| ELF | Amin Tarang | Chief Executive Officer | 01.10.2026 | Verkauf | 102,84 | 23.072 | 2.372.611 | Form 4 |
| ELVN | Garland J. Scott | Director | 01.10.2026 | Verkauf | 46,67 | 13.000 | 606.719 | Form 4 |
| ELTK | Dovev Gad | Director | 22.09.2026 | Verkauf | 8,52 | 852 | 7.259 | Form 4 |
| ELTK | Dovev Gad | Director | 17.09.2026 | Verkauf | 8,52 | 4.260 | 36.295 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Verkauf | 51,49 | 289 | 14.881 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Verkauf | 50,72 | 2.194 | 111.270 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.09.2026 | Verkauf | 50,03 | 3.535 | 176.851 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Verkauf | 51,48 | 240 | 12.356 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Verkauf | 50,71 | 1.844 | 93.507 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.09.2026 | Verkauf | 50,03 | 2.916 | 145.891 | Form 4 |
| EL | Fribourg Paul J | Director | 14.09.2026 | Verkauf | 98,79 | 16.137 | 1.594.174 | Form 4 |
| EL | Fribourg Paul J | Director | 14.09.2026 | Verkauf | 98,35 | 27.086 | 2.663.908 | Form 4 |
| EL | Fribourg Paul J | Director | 14.09.2026 | Verkauf | 97,17 | 14.777 | 1.435.881 | Form 4 |
| EL | Fribourg Paul J | Director | 11.09.2026 | Verkauf | 96,78 | 45.000 | 4.355.100 | Form 4 |
| EL | Barshefsky Charlene | Director | 09.09.2026 | Verkauf | 98,82 | 3.775 | 373.046 | Form 4 |
| ELF | Fields Mandy J | See Remarks | 08.09.2026 | Verkauf | 106,61 | 600 | 63.967 | Form 4 |
| ELF | Fields Mandy J | See Remarks | 08.09.2026 | Verkauf | 105,65 | 2.850 | 301.092 | Form 4 |
| ELF | Fields Mandy J | See Remarks | 08.09.2026 | Verkauf | 104,73 | 4.650 | 486.985 | Form 4 |
| ELF | Fields Mandy J | See Remarks | 08.09.2026 | Verkauf | 103,83 | 7.965 | 827.019 | Form 4 |
| ELF | Franks Joshua Allen | SVP, Operations | 08.09.2026 | Verkauf | 110,00 | 200 | 22.000 | Form 4 |
| ELF | Franks Joshua Allen | SVP, Operations | 01.09.2026 | Verkauf | 110,00 | 5.512 | 606.320 | Form 4 |
| EL | La Lande Rashida | Exec VP & General Counsel | 28.08.2026 | Verkauf | 103,32 | 7.766 | 802.383 | Form 4 |
| EL | La Lande Rashida | Exec VP & General Counsel | 21.08.2026 | Verkauf | 99,55 | 5.564 | 553.896 | Form 4 |
| ELF | Franks Joshua Allen | SVP, Operations | 19.08.2026 | Verkauf | 100,00 | 5.718 | 571.800 | Form 4 |
| ELF | Levitan Lauren Cooks | Director | 18.08.2026 | Verkauf | 93,15 | 1.034 | 96.321 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.08.2026 | Verkauf | 59,35 | 1.388 | 82.383 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.08.2026 | Verkauf | 58,35 | 4.630 | 270.168 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.08.2026 | Verkauf | 59,35 | 1.100 | 65.281 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.08.2026 | Verkauf | 58,37 | 3.900 | 227.650 | Form 4 |
| ELF | Marchisotto Kory | See Remarks | 04.08.2026 | Verkauf | 88,02 | 12.173 | 1.071.415 | Form 4 |
| ELVN | Derynck Mika K | Director | 04.08.2026 | Verkauf | 60,21 | 158.795 | 9.561.587 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 53,87 | 123 | 6.626 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 53,38 | 2.638 | 140.823 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 52,32 | 2.564 | 134.143 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 51,48 | 369 | 18.997 | Form 4 |
| ELVN | Hohl Benjamin | CHIEF FINANCIAL OFFICER | 17.07.2026 | Verkauf | 49,97 | 324 | 16.191 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 53,92 | 63 | 3.397 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 53,42 | 2.184 | 116.669 | Form 4 |
| ELVN | Collins Helen Louise | CHIEF MEDICAL OFFICER | 17.07.2026 | Verkauf | 52,39 | 2.063 | 108.085 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).